10x Genomics Past Earnings Performance

Past criteria checks 0/6

10x Genomics's earnings have been declining at an average annual rate of -3.4%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 20.3% per year.

Key information

-3.4%

Earnings growth rate

12.2%

EPS growth rate

Life Sciences Industry Growth36.9%
Revenue growth rate20.3%
Return on equity-25.3%
Net Margin-29.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How 10x Genomics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0A88 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24630-183331260
30 Jun 24632-240332261
31 Mar 24625-264337269
31 Dec 23619-255336268
30 Sep 23591-223331267
30 Jun 23568-172322268
31 Mar 23536-174312267
31 Dec 22516-166296264
30 Sep 22504-167289264
30 Jun 22498-142278251
31 Mar 22499-89267234
31 Dec 21490-58258212
30 Sep 21459-455244190
30 Jun 21406-504233165
31 Mar 21333-533209139
31 Dec 20299-543202123
30 Sep 20262-134185112
30 Jun 20251-78166104
31 Mar 20264-4915494
31 Dec 19246-3113183
30 Sep 19221-10011968
30 Jun 19197-10510557
31 Mar 19170-1059451
31 Dec 18146-1128848
31 Dec 1771-194732

Quality Earnings: 0A88 is currently unprofitable.

Growing Profit Margin: 0A88 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0A88 is unprofitable, and losses have increased over the past 5 years at a rate of 3.4% per year.

Accelerating Growth: Unable to compare 0A88's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0A88 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).


Return on Equity

High ROE: 0A88 has a negative Return on Equity (-25.26%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies